Search NLS News

The capital investment from Omnio’s shareholders will be used for ongoing development work and to begin creating a blueprint for manufacturing. The company has already made a number of physician-led studies and successful trials involving patients with clinical wounds, they state in their press release. “It is unbelievable what some people have to go through […]

Forxiga has been approved in China to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease (ESKD), cardiovascular (CV) death and hospitalisation for heart failure (hHF) in adults with chronic kidney disease (CKD) at risk of progression with and without type-2 diabetes (T2D). The approval by China’s National Medical Products […]

Salipro Biotech has announced that its patent entitled “Saposin lipoprotein particles and libraries from crude membranes” has been issued by both the U.S. Patent and Trademark Office and by the China National Intellectual Property Administration. The patents cover the company’s novel method of direct extraction of membrane proteins (DirectMX) from cells or crude membranes to […]

The Gothenburg based company has announced that an article has been published in Neurology, from the American Academy of Neurology, describing data from the company’s IPO-001 pharmacokinetic cross-over study. In a pharmacokinetic cross-over study comprising 18 evaluable subjects with advanced Parkinson’s disease, levodopa/carbidopa solutions with a pH of 5.5 were produced by continuous buffering shortly […]

The company has received a research grant of 5 million SEK from Sweden’s Innovation Agency, to develop preclinical proof of concept for a novel synthetic small polypeptide for the treatment of multiple myeloma. “I am very proud and exhilarated that we have managed to attract world-leading expertise to our research consortium around NK-cell engagers,” said […]

Imfinzi has been approved in the US for the treatment of adult patients with locally advanced or metastatic biliary tract cancer (BTC) in combination with chemotherapy (gemcitabine plus cisplatin). The approval by the Food and Drug Administration (FDA) was based on the results from the TOPAZ-1 Phase III trial. In an interim analysis of TOPAZ-1, […]

IRLAB Therapeutics have announced that its partner Ipsen has initiated clinical studies with drug candidate mesdopetam in accordance with its development plan. These are standard clinical pharmacokinetic studies that will run in parallel to the Phase IIb study with mesdopetam that is currently being conducted by IRLAB with results anticipated around the end of the […]

BioInvent International has announced the completion of the planned dose escalation part of its Phase 1/2a trial of the anti-TNFR2 drug candidate BI-1808. Given the positive safety and tolerability profile observed so far, a higher dose of BI-1808 as single agent will be tested to explore the effect of higher exposure, states the company. In […]

Orientation Marketing has opened a new office in Espoo, Finland. The new office has been opened in order to serve the company’s growing client base in the Nordic and EU regions, it states in a press release. The new office will be managed through agency Co-Founder, Chris Lawson and Account Director, Anne Lawson. “With office […]

Center for Translational Research AB acquires Admescope’s Swedish operation (changing name to Metasafe) and strengthens collaboration with Admescope and Symeres. Center for Translational Research CTR is a group of complementary life science service companies providing expert services and advice within product development. The services provided by Admescope Sweden/Metasafe complements well the current offerings and will […]